Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,317,621 papers from all fields of science
Search
Sign In
Create Free Account
psychoactive substances
Known as:
agents affecting mood and behavior
, narcotics (any psychoactive drug)
, psychoactive substance
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
Central Nervous System Agents
Narcotic Analgesics
Narrower (1)
Psychotropic Drugs
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Assessment of tobacco, alcohol and cannabinoid metabolites in 645 meconium samples of newborns compared to maternal self-reports.
S. Lamy
,
B. Hennart
,
+6 authors
F. Thibaut
Journal of Psychiatric Research
2017
Corpus ID: 206466486
Review
2017
Review
2017
Access to treatment with controlled medicines rationale and recommendations for neutral, precise, and respectful language.
Willem Scholten
,
Olivier Simon
,
+4 authors
Lukas Radbruch
Public Health
2017
Corpus ID: 21316394
Review
2017
Review
2017
Reliability of point‐of‐collection testing devices for drugs of abuse in oral fluid: A systematic review and meta‐analysis
J. Scherer
,
T. R. Fiorentin
,
+5 authors
F. Pechansky
Journal of Pharmaceutical and Biomedical Analysis
2017
Corpus ID: 24190132
Review
2016
Review
2016
Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings
M. T. Zanda
,
P. Fadda
,
C. Chiamulera
,
W. Fratta
,
L. Fattore
Behavioural Pharmacology
2016
Corpus ID: 3657823
An increasing number of novel psychoactive substances are currently available and sold as ‘legal highs’ or ‘research chemicals…
Expand
2014
2014
Socio-Psycological Characteristics of College Students Who are Prone to Addictions
Elena A. Cheverikina
,
Rezeda Munavirovna Rakhimgarayeva
,
V. V. Sadovaya
,
V. Zakirova
,
Olga Dmitrievna Starodubets
,
V. S. Klemes
2014
Corpus ID: 34936446
Addictive behavior in the modern world is a disincentive factor for personal-professional development of students. The purpose of…
Expand
2009
2009
Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder.
C. Stockmeier
,
Eimear Howley
,
+4 authors
G. Rajkowska
Journal of Psychiatric Research
2009
Corpus ID: 34459696
Review
2004
Review
2004
Opportunities for an improved role for nurses in psychoactive substance use: review of the literature.
A. Nkowane
,
S. Saxena
International Journal of Nursing Practice
2004
Corpus ID: 44967702
Nurses form a core component of many health care systems so their role in responding to problems related to psychoactive…
Expand
1998
1998
Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorders.
S. Milberger
,
S. Faraone
,
J. Biederman
,
M. Chu
,
T. Wilens
Archives of Pediatrics & Adolescent Medicine
1998
Corpus ID: 15443144
OBJECTIVE To test hypotheses about patterns of familial association between attention-deficit/hyperactivity disorder (ADHD) and…
Expand
1994
1994
Longitudinal, Expert, All Data Procedure for Psychiatric Diagnosis in Patients with Psychoactive Substance Use Disorders
H. Kranzler
,
R. Kadden
,
T. Babor
,
B. Rounsaville
Journal of Nervous and Mental Disease
1994
Corpus ID: 45983159
The Longitudinal, Expert, All Data (LEAD) procedure has been proposed as a criterion for the assessment of the procedural…
Expand
Review
1991
Review
1991
Opportunities for treatment of psychoactive substance use disorders with serotonergic medications.
Edward M. Sellers
,
Guy A. Higgins
,
Tomkins Dm
,
M. Romach
,
Tony Toneatto
Journal of Clinical Psychiatry
1991
Corpus ID: 19918684
The authors review both the preclinical and the clinical evidence for a role of serotonin (5-HT) systems in the regulation of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE